关于茂名石化实华股份有限公司 2024 年度 非经营性资金占用及 其他关联资金往来情况的专项说明 中兴财光华审专字（2025）第 226026 号 1 关于茂名石化实华股份有限公司 2024 年度非经营性资金占用及 其他关联资金往来情况的专项说明 中兴财光华审专字（2025）第 226026 号 茂名石化实华股份有限公司全体股东： 目 录 关于茂名石化实华股份有限公司 2024 年度非经 营性资金占用及其他关联资金往来情况的专项 说明 茂名石化实华股份有限公司 2024 年度非经营性 资金占用及其他关联资金往来情况汇总表 我们接受茂名石化实华股份有限公司（以下简称"茂化实华"）委托，根据 中国注册会计师执业准则审计了茂名石化实华股份有限公司 2024 年 12 月 31 日 的合并及公司资产负债表，2024 年度合并及公司利润表、合并及公司现金流量表、 合并及公司股东权益变动表和财务报表附注，并出具了中兴财光华审会字（2025） 第 226021 号无保留意见审计报告。 根据《上市公司监管指引第 8 号——上市公司资金往来、对外担保的监管要 求》（证监会公告[2022]26 号）及《深圳证券交易所上市公司自律 ...

茂名石化实华股份有限公司 | 合并及公司资产负债表 | 1-2 | | --- | --- | | 合并及公司利润表 | 3 | | 合并及公司现金流量表 | 4 | | 合并及公司股东权益变动表 | 5-8 | | 财务报表附注 | 9-96 | 审计报告 中兴财光华审会字（2025）第 226021 号 茂名石化实华股份有限公司全体股东： 中兴财光华审会字（2025）第 226021 号 | 目录 | | --- | 审计报告 一、审计意见 我们审计了茂名石化实华股份有限公司（以下简称茂化实华）财务报表， 包括 2024 年 12 月 31 日的合并及公司资产负债表，2024 年度的合并及公司利润 表、合并及公司现金流量表、合并及公司股东权益变动表以及财务报表附注。 我们认为，后附的财务报表在所有重大方面按照企业会计准则的规定编制， 公允反映了茂化实华 2024 年 12 月 31 日的合并及公司财务状况以及 2024 年度的 合并及公司经营成果和现金流量。 二、形成审计意见的基础 我们按照中国注册会计师审计准则的规定执行了审计工作。审计报告的 "注册会计师对财务报表审计的责任"部分进一步阐述了我们在这些 ...

关于茂名石化实华股份有限公司 2024 年度营业收入 扣除事项的专项核查意见 中兴财光华审专字（2025）第 226027 号 目 录 茂化实华管理层负责按照《深圳证券交易所股票上市规则（2024 年修订）》 和《深圳证券交易所上市公司自律监管指南第 1 号——业务办理（2024 年修 订）》的规定编制营业收入扣除情况表，并设计、执行和维护必要的内部控 制，以使营业收入扣除情况表不存在由于舞弊或错误导致的重大错报。 二、注册会计师的责任 我们的责任是在执行核查工作的基础上对营业收入扣除情况表发表专项 核查意见。我们按照中国注册会计师审计准则的规定执行核查工作。中国注 册会计师审计准则要求我们遵守中国注册会计师职业道德守则，计划和执行 核查工作，以对营业收入扣除情况表是否不存在重大错报获取合理保证。在 核查过程中，我们实施了包括检查会计记录等我们认为必要的程序。我们相 信，我们的核查工作为发表意见提供了合理的基础。 三、专项核查意见 关于茂名石化实华股份有限公司 2024 年度营 业收入扣除事项的专项核查意见 茂名石化实华股份有限公司 2024 年度营业收 入扣除情况表 关于茂名石化实华股份有限公司 2024 ...

中兴财光华审专字（2025）第 226024 号 茂名石化实华股份有限公司 内部控制审计报告 中兴财光华审专字（2025）第226024号 茂名石化实华股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求， 我们审计了茂名石化实华股份有限公司（以下简称"茂化实华"）2024 年 12 月 31 日的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》《企业内部控制应用指引》《企业内部 控制评价指引》的规定，建立健全和有效实施内部控制，并评价其有效性是 茂化实华董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上，对财务报告内部控制的有效性发表 审计意见，并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、内部控制的固有局限性 内部控制具有固有局限性，存在不能防止和发现错报的可能性。此外，由于 情况的变化可能导致内部控制变得不恰当，或对控制政策和程序遵循的程度降 低，根据内部控制审计结果推测未来内部控制的有效性具有一定风险。 四、财务报告内部控制审计意见 我们认为，茂化实华于2024年12月31日按照《企业内部控制基本规范》 ...

Financial Performance - The company's operating revenue for 2024 was ¥3,754,940,782.49, a decrease of 17.43% compared to ¥4,547,810,680.92 in 2023[20] - The net profit attributable to shareholders was -¥83,383,070.82, improving by 34.77% from -¥127,833,708.40 in the previous year[20] - The net cash flow from operating activities significantly dropped to ¥9,077,909.18, a decrease of 97.43% from ¥353,022,150.03 in 2023[20] - Basic and diluted earnings per share were both -¥0.16, showing a 36.00% improvement from -¥0.25 in 2023[20] - Total assets at the end of 2024 were ¥2,391,863,344.10, down 4.28% from ¥2,498,846,190.63 at the end of 2023[20] - The net assets attributable to shareholders decreased by 11.42% to ¥645,132,659.65 from ¥728,305,124.36 in 2023[20] - The company reported a significant decline in net profit after deducting non-recurring gains and losses, amounting to -¥187,497,866.28 in 2024, compared to -¥131,498,256.13 in 2023, a decrease of 42.59%[20] - The weighted average return on equity was -12.14%, an improvement of 22.28% from -15.62% in 2023[20] Industry Context - The total revenue for the petrochemical industry in China in 2024 was ¥16.28 trillion, representing a year-on-year growth of 2.1%[30] - The total profit for the petrochemical industry in 2024 was ¥789.71 billion, showing a year-on-year decline of 8.8%[30] - The import value of petrochemical products in 2024 was approximately $625.76 billion, a decrease of 3% year-on-year[30] - The gross profit margin for the petroleum and chemical sector dropped to 1.92%, a decline of 44.69% compared to the previous year[92] Strategic Initiatives - The company plans not to distribute cash dividends or issue bonus shares[5] - The company plans to leverage state-owned resources for project construction and industry development, aiming for enhanced competitiveness[32] - The company is positioned to explore opportunities in the hydrogen energy sector as part of the national energy transition strategy[33] - The company aims to enhance its market share and brand recognition for new products such as hydrogen peroxide and modified polypropylene[58] - The company plans to optimize existing main business technologies and production, focusing on market trends for polypropylene, MTBE, and other products to enhance efficiency and reduce costs[124] - The company aims to diversify its operations through mergers and acquisitions in new materials, green chemicals, and renewable energy sectors to achieve breakthroughs in industrial transformation[137] Research and Development - The company has established two provincial-level fine chemical engineering technology R&D centers and holds over 60 proprietary patents[59] - Research and development expenses increased by 64.27% to CNY 16,260,952.20, primarily due to an increase in R&D projects[100] - The company has invested 50 million RMB in R&D for new technologies, focusing on sustainability and efficiency improvements[186] Operational Efficiency - The company achieved zero major safety accidents and zero environmental incidents, maintaining a strong safety and environmental performance[51] - A total of 20.97 million yuan was invested in safety hazard rectification, completing 5 major equipment inspections and 43 technical improvement projects[52] - The company optimized production efficiency, resulting in a cost reduction of approximately 7.9 million yuan through direct procurement of 19,710 tons of fuel oil[75] - The company is committed to improving operational efficiency, targeting a 5% reduction in operational costs by the end of the fiscal year[186] Governance and Management - The company completed the change of controlling shareholder in April 2024, with the new controlling shareholder being Maoming Port Group Co., Ltd.[149] - The company has established an independent director system and specialized committees within the board to enhance corporate governance and compliance oversight[155] - The company has implemented a new governance structure with the election of new independent directors and supervisors to strengthen oversight and compliance[172] - The company has maintained strict adherence to information disclosure obligations, ensuring all shareholders have equal access to information[151] Market Expansion - The company is exploring market expansion opportunities in Southeast Asia, targeting a 25% increase in market penetration by the end of 2024[186] - A strategic acquisition is planned, with negotiations ongoing for a potential merger with a local competitor, which could enhance operational capabilities[186] Financial Management - The company’s financial management policies were reviewed and approved on July 25, 2024, to establish a new remuneration management system for senior management[198] - Total remuneration for directors, supervisors, and senior management during the reporting period amounted to CNY 9.591 million[196] - The highest remuneration was received by the Deputy General Manager Gu Jiajie, totaling CNY 2.0555 million[197] Challenges and Risks - The company faces uncertainties in achieving its 2025 operational goals due to industry policies and market demand fluctuations[4] - The company anticipates a significant increase in polypropylene production capacity, with an expected release of 7.1 million tons per year, which may lead to price declines and compressed profit margins[130] - The company faces significant macroeconomic risks, including a potential decline in exports to the US due to increased tariffs, which could compress market space and impact sales revenue and profits[126]

茂化实华（000637）公告，2025年第一季度营业收入7.88亿元，同比下降34.00%。净亏损3506.79万 元，去年同期净亏损4398.72万元。 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥787,871,572.11, a decrease of 34.00% compared to ¥1,193,726,277.45 in the same period last year[5] - The net loss attributable to shareholders was ¥35,067,900.21, showing an improvement of 20.28% from a loss of ¥43,987,180.18 in the previous year[5] - The company reported a net loss of ¥152,877,426.57, compared to a loss of ¥117,809,526.36 in the previous period[19] - The company reported a net loss of ¥38,631,962.69, compared to a net loss of ¥40,454,995.71 in the previous period, indicating an improvement of approximately 4.5%[22] - The company’s total profit (loss) amounted to -¥37,447,968.75, slightly improved from -¥37,851,260.73 in the previous period[21] Cash Flow - The net cash flow from operating activities decreased by 85.78%, down to ¥6,017,240.48 from ¥42,303,774.67 year-on-year[5] - Operating cash flow for the period was ¥6,017,240.48, a significant decrease from ¥42,303,774.67 in the prior period, reflecting a decline of about 85.8%[24] - The net cash flow from financing activities was ¥65,623,182.23, compared to ¥44,941,781.75 in the prior period, showing an increase of about 46%[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,313,974,535.69, a decline of 3.26% from ¥2,391,863,344.10 at the end of the previous year[5] - Total current assets decreased to ¥771,795,092.50 from ¥830,352,316.24, a reduction of about 7%[18] - Total liabilities decreased to ¥1,591,427,524.99 from ¥1,633,783,213.13, reflecting a reduction of about 3%[19] - Total equity attributable to shareholders decreased by 5.02% to ¥612,736,296.52 from ¥645,132,659.65 at the end of the previous year[5] Earnings Per Share - The company's basic and diluted earnings per share were both -¥0.07, an improvement of 12.50% from -¥0.08 in the same period last year[5] - The company’s basic and diluted earnings per share were both reported at -¥0.07, an improvement from -¥0.08 in the previous period[22] Research and Development - Research and development expenses decreased by 49.94% to ¥2,539,915.58 from ¥5,073,743.34 year-on-year, primarily due to a reduction in R&D projects[8] - Research and development expenses were ¥2,539,915.58, down from ¥5,073,743.34, indicating a decrease of about 50%[20] Shareholder Information - The total number of common shareholders at the end of the reporting period is 24,126, with no preferred shareholders having restored voting rights[9] - The largest shareholder, Maoming Port Group, holds 154,917,345 shares, representing 29.80% of the total shares[9] - China Petroleum & Chemical Corporation holds 76,658,001 shares, accounting for 14.75% of the total shares[9] - The controlling shareholder, Maoming Port Group, plans to increase its stake by investing between RMB 10 million and RMB 20 million, aiming for a total increase of 0.65% of the company's issued share capital[11] - As of January 22, 2025, Maoming Port Group has completed its share purchase, acquiring 3,379,200 shares for approximately RMB 12.43 million[11] - The company has no related party relationships among the top ten shareholders, ensuring compliance with regulations[9] - The top ten shareholders do not participate in margin financing or securities lending, except for specific individuals holding shares through credit trading accounts[9] Other Income - The company reported a significant increase in other income, which rose by 3054.44% to ¥438,503.42 compared to ¥13,901.16 in the previous year[8] Operating Costs - Total operating costs amounted to ¥829,088,506.90, down from ¥1,233,323,720.34, indicating a reduction of about 33%[20] - Operating costs included ¥759,539,233.29 in cost of goods sold, which decreased from ¥1,161,334,573.30, reflecting a 35% decline[20] Investment Income - The company achieved investment income of ¥1,225,411.60, compared to no investment income in the previous period, indicating a positive development[21]

证券代码：000637 证券简称：茂化实华 公告编号：2025-007 茂名石化实华股份有限公司 关于公开挂牌转让的茂名市开元氮肥有限公司、茂名 市威龙化学工业有限公司、茂名市威龙商贸有限公司 不良债权已收到全部转让价款及利息的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、交易的基本情况 茂名石化实华股份有限公司（以下简称"公司"）于 2024 年 9 月 12 日召开第十三届董事会第三次临时会议，审议通 过了《关于拟公开挂牌转让茂名市开元氮肥有限公司、茂名 市威龙化学工业有限公司、茂名市威龙商贸有限公司不良债 权的议案》，同意以公开挂牌转让的方式转让茂名市开元氮 肥有限公司（以下简称"开元氮肥"）、茂名市威龙化学工 业有限公司（以下简称"威龙化工"）、茂名市威龙商贸有 限公司（以下简称"威龙商贸"）的不良债权（以下统称"标 的债权"）。2024 年 9 月 30 日公司召开的 2024 年第四次临 时股东会，审议批准挂牌转让标的债权事宜。 经过评估测算，评估基准日 2024 年 8 月 31 日，公司委 托评估的用于本次评估目的的指定资产的评估价 ...

- 1 - 证券代码：000637 证券简称：茂化实华 公告编号：2025-006 茂名石化实华股份有限公司 关于独立董事辞职的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 茂名石化实华股份有限公司（以下简称"公司"）董事 会于 2025 年 4 月 11 日收到公司独立董事张保国先生的《辞 职报告》。 张保国先生因个人原因申请辞去公司第十三届董事会 独立董事职务，同时申请辞去公司第十三届董事会战略委员 会召集人、审计委员会委员、提名与薪酬考核委员会委员职 务。辞职后，张保国先生不再担任公司任何职务。 张保国先生的辞职将导致公司独立董事人数少于董事 会成员的三分之一，根据《中华人民共和国公司法》《上市 公司独立董事管理办法》《公司章程》等相关规定，在公司 收到张保国先生辞职报告之日起至公司股东会选举产生新 的独立董事期间，张保国先生仍将继续履行独立董事及董事 会各专门委员会召集人或委员的职责。公司董事会将按照相 关规定，尽快完成独立董事的补选工作。 张保国先生在担任公司独立董事期间恪尽职守、勤勉尽 责，公司及董事会对张保国先生在任职期间为公司所做出的 ...

证券代码：000637 证券简称：茂化实华 公告编号：2025-005 茂名石化实华股份有限公司 关于控股股东增持公司股份计划实施完成的公告 茂名港集团有限公司保证向本公司提供的信息内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1.茂名石化实华股份有限公司（以下简称"公司"）于 2024 年 10 月 22 日披露了《关于控股股东股份增持计划的公告》（公告编号： 2024-080），公司控股股东茂名港集团有限公司（以下简称"茂名港 集团"）计划自 2024 年 10 月 22 日起的 6 个月内，以不低于人民币 1,000 万元，不高于人民币 2,000 万元，通过深圳证券交易所交易系 统允许的方式（包括但不限于集中竞价交易、大宗交易）增持公司股 份，累计增持比例预计为公司已发行总股本的 0.65%。 2.截至本公告披露日，本次增持计划已实施完毕。茂名港集团通 过深圳证券交易所以集中竞价方式累计增持公司股份 3,379,200 股， 占公司已发行总股本的 0.65%，累计增持金额约为人 ...